HXB Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - AIM ImmunoTech Inc

Watchlist Manager

Watchlist

Price: 0.121 EUR 5.22% Market Closed

Market Cap: €4.8m

A	AIM ImmunoTech Inc XMUN:HXB	US
	COMSovereign Holding Corp OTC:COMS	US
	Indocement Tunggal Prakarsa Tbk PT OTC:PITPF	ID
	Aker Solutions ASA OTC:AKRTF	NO
R	Red Planet Japan Inc SWB:DN3	JP
	Windar Photonics PLC F:7WP	DK
G	Givaudan SA SWB:GIN	CH
	VBX Ltd F:YU8	AU
	Megawatt Lithium and Battery Metals Corp F:WR20	CA

Profitability Summary

AIM ImmunoTech Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Negative Gross Margin

-23%

Sustainable 3Y Average Gross Margin

41%

Declining Gross Margin

84% > -23%

Negative Operating Margin

-11 724%

Negative 3Y Average Operating Margin

-13 623%

Operating Margin is Increasing

-12 160% > -11 724%

Negative Net Margin

-15 021%

Negative 3Y Average Net Margin

-13 640%

Declining Net Margin

-10 764% > -15 021%

Negative Free Cash Flow Margin

-15 385%

Negative 3Y Average Free Cash Flow Margin

-11 283%

Declining Free Cash Flow Margin

-9 399% > -15 385%

Negative ROE

-2 382%

Exceptional 3Y Average ROE

Exceptional 3Y Average ROIC

185%

ROIC is Increasing

-418% > 1 298%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.